Tan Lines

culture

Tanorexia: the opioid your skin makes in the sun

Published August 18, 2026

Every other section of this site can tell you what Melanotan II is, where it came from, and what it costs. None of that answers the question underneath the whole story: why would anyone want a tan badly enough to inject an untested peptide into their stomach? The easy answer is vanity. The more honest answer is that wanting a tan was never purely a decision. Your skin runs a reward circuit, and the sun knows how to work it.

The molecule that tans you also doses you

When ultraviolet light hits the skin, it damages DNA in keratinocytes — the outer skin cells — and that damage switches on a gene called POMC, pro-opiomelanocortin. POMC is a precursor: a long protein the cell snips into several smaller ones. Two of those pieces matter here. One is α-MSH, the melanocyte-stimulating hormone that is the entire subject of how the tanning signal really works — it tells pigment cells to make melanin. The other is β-endorphin, an endogenous opioid from the same chemical family as morphine.

Read that again, because it is the crux of this whole pillar. The same molecular event that browns your skin also releases an opioid inside it. The tan is the visible product. The endorphin is the hidden one.

The reward loop the sun runs UV light drives skin cells to make POMC, which splits into alpha-MSH (the tan) and beta-endorphin (an opioid). The opioid reward creates a pull to seek more sun, closing a loop. The loop the sun runs One event in the skin tans you and doses you — with an opioid your own cells make. UV light skin cell keratinocyte POMC the precursor α-MSH → pigment the tan — the visible half β-endorphin → reward an opioid, morphine’s family the pull to do it again
The pathway behind the pull. UV light drives skin cells to make POMC, which is cut into two products at once: α-MSH, which triggers the tan, and β-endorphin, an endogenous opioid. In animals, blocking that opioid produces genuine withdrawal — the sun runs a small reward loop, and the tan is only its visible half.

The mice that got hooked

For a long time “tanning addiction” sounded like a figure of speech. Then, in 2014, David Fisher’s lab at Massachusetts General Hospital put it on a mechanism. Writing in Cell, the team exposed mice to chronic low-dose UV and watched their blood: β-endorphin rose, and the animals’ pain thresholds rose with it — a classic opioid effect, since opioids blunt pain. The mice were, biochemically, mildly high.

Then the researchers blocked the opioid with naloxone, the same antagonist paramedics use to reverse a heroin overdose. The analgesia vanished — and the UV-habituated mice began to tremble, shake, and chatter their teeth: the textbook signs of opioid withdrawal. A separate strain of mice engineered so their skin could not make POMC, or that lacked the β-endorphin gene entirely, showed none of it — no high, no withdrawal. That is about as clean as a causal story gets. The reward was coming from the skin, not the imagination.

Eight frequent tanners

Mice are not people, and the honest caveats matter here more than usual. But there is a human hint, and it points the same way. In a small randomized trial published in 2006 in the Journal of the American Academy of Dermatology, researchers gave the opioid blocker naltrexone to habitual tanners. Four of the eight frequent tanners — and none of the infrequent ones — developed withdrawal-like symptoms: nausea, jitteriness, the feeling of being “emotionally drained.” Opioid blockade also nudged down their preference for a UV light source over a sham one.

Eight people is not a mountain of evidence, and “tanorexia” is not a diagnosis you will find settled in a manual — it remains under investigation, and this site is not going to inflate a small study into a certainty. But the direction is consistent, from mouse to human: for some heavy tanners, the drive looks less like a preference and more like a dependence with a chemical floor under it.

What this explains about a peptide

Here is the site’s reading of why any of this belongs in the Melanotan story.

Melanotan II is a synthetic mimic of α-MSH. It plugs straight into the pigment half of that ancient POMC circuit — it is, in effect, the tanning signal delivered without the sun. What it does not deliver is the β-endorphin. It is a receptor agonist, not a dose of UV, so it does not hand you the opioid reward directly.

But it did not have to. The demand it walked into was already built. A century of culture had made a tan aspirational — that is its own story — and underneath the fashion, biology had wired a genuine reward into the act of getting one. By the time a peptide arrived promising the color with none of the sunburn, it was selling to a market whose appetite the sun had spent millennia cultivating. “Just wear sunscreen” was never going to win that argument, because it was never only an argument about looks.

The tan, in other words, was never merely cosmetic. It sits on a reward pathway older than fashion, older than melanoma, older than us. Which is exactly why the gray market never wanted for customers — and why the only thing that ever plausibly competes with a want this deep is a safe, legitimate way to satisfy it.